Bosentan Tablets for Oral Suspension and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Bosentan Tablets for Oral Suspension and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bosentan
Brand name: Tracleer
Synonyms: Bosentan
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bosentan Tablets for Oral Suspension-Moxifloxacin
- Bosentan Tablets for Oral Suspension-Moxifloxacin (Systemic)
- Bosentan Tablets for Oral Suspension-Moxifloxacin Hydrochloride
- Bosentan Tablets for Oral Suspension-Moxifloxacin Injection
- Bosentan Tablets for Oral Suspension-Moxifloxacin Intravenous
- Bosentan Tablets for Oral Suspension-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Bosulif
- Moxetumomab pasudotox-tdfk Intravenous-Bosutinib
- Moxetumomab pasudotox-tdfk Intravenous-Botox
- Moxetumomab pasudotox-tdfk Intravenous-Botox Cosmetic
- Moxetumomab pasudotox-tdfk Intravenous-Botulism immune globulin
- Moxetumomab pasudotox-tdfk Intravenous-Botulism Immune Globulin (Intravenous-Human)